Top

Reactions Weekly

Published in:

01-05-2024 | Abatacept | Case report

Abatacept/cyclophosphamide

Lack of efficacy and off-label use in unapproved indication

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kaur S, et al. Graft-Versus-Host Disease (GvHD) Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation (haplo-PBSCT) Using Abatacept in Combination with Post-Transplant Cyclophosphamide (PTCy). Blood 142 (Suppl.): 6996-6997, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-184901 [abstract]

Title: Abatacept/cyclophosphamide
Lack of efficacy and off-label use in unapproved indication
Publication date: 01-05-2024
Publisher: Springer International Publishing
Keywords: Abatacept
Graft-Versus-Host Disease
Graft-Versus-Host Disease
Stem Cell Transplantation
Stem Cell Transplantion
Stem Cell Transplantation
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-57908-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abatacept/cyclophosphamide

Lack of efficacy and off-label use in unapproved indication

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Semaglutide/Tacrolimus

Bevacizumab/niraparib/olaparib

Ceftriaxone/Vancomycin

Multiple drugs

Decitabine

Clarithromycin